Predicting the likely success of primary PCI to salvage potential infarcted myocardium is desirable. We compared early invasive parameters of coronary microcirculation function with the levels of circulating endothelin (ET-1) and 6-month ejection fraction after STEMI.
Introduction
Primary angioplasty (PPCI) restores TIMI III flow in over 90% of patients and improves clinical outcomes from acute ST-elevation myocardial infarction (STEMI). 1 Microcirculatory no-reflow can be identified in nearly one-third of patients undergoing PPCI and is associated with both the extent of myocardial infarction and leftventricular (LV) dysfunction. 2 -4 A recent National Heart Lung and Blood Institute Cardioprotection Workshop identified the microcirculation as an important target to further improve the outcomes from reperfusion therapy. 5 Changes in the coronary microcirculation after STEMI have been described in non-invasive studies using myocardial contrast and Doppler echocardiography, 6, 7 positron-emission tomography, 8 and † These authors contributed equally. ‡ These authors contributed equally.
CMR. 9 Early invasive studies investigated coronary flow reserve (CFR) after thrombolysis. Lepper showed CFR .1.6 at 24 h was associated with contrast echocardiographic measures of reperfusion, and LV function. 10 Feldman extended these observations in 21 patients with anterior STEMI showing that worsening electrocardiographic ST-elevation during PPCI was associated with lower CFR, larger infarct size, and worse LV function 11 , and in a subsequent study that lower procedural post-stent CFR was related to incomplete ST-resolution after PPCI. 12 Recently, the Index of Microcirculatory Resistance (IMR) has been studied at the time of PPCI and in small populations there are correlations with total creatine kinase release, LV function, and myocardial salvage. 13, 14 There is increasing interest in trying to identify measures of the microcirculation such as CFR and IMR 'at the time of PPCI'. Not only would this measure reflect the efficacy of reperfusion but it would also allow comparison of different adjunctive strategies designed to improve treatment. However, the impact of changes of microcirculatory function within the early post-reperfusion period on later ejection fraction and salvage and has not been specifically addressed. Furthermore, the mechanisms contributing to impaired microvascular dysfunction after PPCI are unclear.
The aims of our study were to identify how measures of microcirculatory function at PPCI and Day 1 after STEMI relate to the extent of injury measured by troponin release, levels of endothelin-1, and ejection fraction and myocardial salvage measured by MRI.
Methods

Study patients
The study population consisted of 45 prospectively enrolled STEMI patients who underwent PPCI at the John Radcliffe Hospital, Oxford [Oxford Studies In Acute Myocardial Infarction (Ox-AM) Cohort]. STEMI was defined as chest pain continuing for .30 min and ST elevation .2 mm in .2 contiguous leads. Exclusion criteria were symptom duration .12 h, the presence of severe haemodynamic instability, and contraindication to the use of adenosine. The study was conducted in accordance with the Declaration of Helsinki. The local Ethics Committee approved the protocol and all participants gave written informed consent (REC number 10/H0408/24).
Coronary intervention
PPCI was performed in a standard fashion in line with international guidelines. Patients received oral aspirin (300 mg) and thienopyridines (600 mg clopidogrel or 60 mg prasugrel) pre-procedure. Thrombus aspiration and use of abciximab (ReoPro w , Eli Lilly, USA) and bivalirudin (Angiox, The Medicines Company, USA) before pre-dilatation and stent deployment were recommended but were at the discretion of the primary operator.
Evaluation of coronary microcirculation
The pressure wire (Certus, St Jude Medical, St Paul, MN, USA) was placed in the distal third of the infarct-artery (IRA) to perform invasive assessment of the coronary microcirculation immediately after stent implantation + post-dilatation. Care was taken that the wire remained stable and its position was documented for repeat study. Side branches were used as anatomical landmarks. CFR, IMR, and fractional flow reserve (FFR) were measured using previously described methods. 15 -17 Briefly, the shaft and the sensor near the tip of the pressure wire act as thermistors, and by detecting changes in temperature after the injection of room-temperature saline transit times can be measured. The transit time (T mn ) was calculated as a mean from three injections of 5 mL roomtemperature saline through the guiding catheter. T mn was recorded at baseline and after induction of hyperaemia with intravenous adenosine infusion (140 mg kg 21 min 21 for 120 s) into the right femoral vein. Simultaneous measurement of mean aortic pressure (Pa, by guiding catheter) and mean distal coronary pressure (Pd, by pressure wire) was made in the resting and maximal hyperaemic states. CFR was calculated as the ratio of the transit times at baseline and hyperaemia. IMR was calculated as the distal coronary pressure at maximal hyperaemia multiplied by the hyperaemic T mn (in seconds). FFR was calculated by the ratio of Pd/Pa at maximal hyperaemia.
Follow-up coronary angiography and evaluation coronary microcirculation
Repeat informed consent was obtained from eligible patients and repeat angiography and pressure wire assessment of the infarct-related artery microcirculatory function was performed the next day following PPCI. Care was taken to use the same type of guiding catheter and wire positioning as at index PPCI.
Angiographic analysis
Coronary flow was graded using the standard Thrombolysis In Myocardial Infarction (TIMI) criteria 18 , while corrected TIMI frame count (CTFC) was measured according to Gibson. 19 Myocardial blush grade (MBG) at the end of the procedure was evaluated according to van't Hof. 20 Angiographic no-reflow was defined as TIMI flow less than grade 3 and/or TIMI 3 flow with MBG less than 2 at completion of the procedure. Angiographic analysis was performed by two interventional cardiologists and disagreement resolved by consensus.
Biochemical assessments
Plasma samples obtained at arrival, immediately post-PPCI and at 6, 24, and 48 h post-PPCI were stored at 2818C. Cardiac Troponin I (cTnI) and quantified with automated chemiluminescent immunoassay techniques on the Siemens ADVIA Centaur (Siemens Healthcare Diagnostics, Frimley, UK). Area under the curve was calculated using the trapezoidal rule to express this as summary measure of infarct size. 21, 22 Endothelin levels were measured using an ELISA QuantiGlo Chemiluminescent Immunoassay (R and D systems, Abingdon, UK).
Magnetic resonance imaging of myocardial injury and salvage
Patients underwent CMR at Day 1 and 6 months. CMR examinations were performed on a 3 Tesla MR scanner (either MAGNETOM TIMTrio or MAGNETOM Verio, Siemens Healthcare, Erlangen, Germany) using a spine coil and a phased array 6-channel flexible surface coil. Left ventricular function and myocardial injury were assessed using Steady State Free Precession (SSFP), T2-weighted and late gadolinium enhancement (LGE) imaging. The images were acquired with each technique on matching short-axis slices. SSFP cine images were acquired using retrospective gating. Oedema imaging (T2W) was performed using a T2-prep-SSFP single shot sequence with surface coil correction. 23 LGE-CMR was performed with a T1-weighted segmented inversionrecovery gradient echo-phase sensitive-inversion recovery sequence. 24 Images were collected 10215 min after the administration of 0.1 mmol/kg contrast agent (Gadodiamide, Omniscan TM , GE Healthcare, Amersham, UK). The inversion time was adjusted for optimal nulling of remote normal myocardium. Quantification of LV volumes and ejection fraction (EF) was performed as previously described using Argus F. Cuculi et al.
software (Version 2002B, Siemens Medical Solutions). For objective quantification of oedema or LGE, a reference region of interest (ROI) was placed in remote myocardium. The signal intensity threshold indicating oedema/LGE was imposed 2 standard deviations above the mean intensity of the reference ROI, as previously described. 25 In the presence of microvascular obstruction (MO) or haemorrhage, both were included in the measurements of LV myocardial damaged volume by LGE and T2W. Furthermore, the amount of haemorrhage and MVO was assessed by manual delineation of the hypointense areas and calculated as percentage fraction of the LV, as previously described 26, 27 (illustrated in Figure 1 ).
In patients with first myocardial infarction and no previous events, salvaged myocardial index was derived from the difference in area between acute oedema and the area of scar by LGE assessed at 6 months.
Statistical analysis
Sample size estimates were based on prior studies showing that a CFR difference of 1.0 between groups was associated with significant differences in infarct size and ejection fraction. 28 Estimated CFR and standard deviation was based on published studies. For 80% power, alpha 0.05, a sample size of 14 was calculated for each group. Recruitment was continued to compensate for potential dropouts and total sample size was set at 45 patients.
Normally distributed parameters are reported as mean + standard deviation (SD) while those with a skewed distribution are reported as median (IQR). For the non-normally distributed variables we used the Mann2Whitney test for unpaired comparisons and the Wilcoxon signed rank test for paired comparisons. For normally distributed variables, we used Student's t-test and Fisher's exact x 2 was used for binary variables. Correlation was assessed using Pearson's correlation. For salvage, effect of post-PPCI CFR and change in CFR between post-PPCI and Day 1 CFR were initially evaluated together in a linear regression model, and clinical factors associated with salvage were sought from standard clinical variables for this patient population. Clinical variables in addition to CFR and IMR were included in a bootstrap resampling procedure (250 re-samples), factors selected in more than 45% of the sample were then included in a multivariable model with backward selection of variables to obtain a final multivariable regression model. Factors included were age, gender, smoking, hypercholesterolaemia, hypertension, diabetes, glycoprotein IIb/IIIa inhibitor, thrombectomy, symptom to reperfusion time, door-to-balloon time, culprit artery, stent size and volume, pre-dilatation, TIMI flow, and ST-segment resolution. All statistical analyses, except ANOVA, were performed using SAS v9.3 (The SAS Institute, Cary, NC, USA). ANOVA was performed using Graphpad Prism. Low EF and high EF group comparisons were made by repeated measures 2-way ANOVA. Time differences within group were analysed by 1-way ANOVA with post hoc Dunn's multiple comparison. A P-value of ,0.05 was considered statistically significant and the tests were two-sided. 
Results
A total of 101 patients with acute STEMI (presenting throughout the 24 h cycle of clinical activity) were screened for inclusion. Eighty-two (81%) patients were recruited and underwent invasive assessment of the coronary microcirculation at PPCI, 61 underwent repeat coronary angiography and coronary microcirculation assessment at Day 1. All patients tolerated adenosine infusion. No significant bradycardia or AV block was observed, and no patient required temporary pacing. Forty-five consented for CMR. Three patients had prior myocardial infarction and were excluded for calculation of salvage index. Clinical characteristics of the 45 patients and angiographic measures of flow are shown in Table 1 .
We stratified the cohort (n ¼ 45) by tertiles of ejection fraction and compared Group 1-those with EF in the lower third (n ¼ Tables 3 and 4 . Importantly, baseline transit times did not differ at these timepoints but hyperaemic transit times shortened significantly at Day 1. In multivariable regression models including clinical variables selected by the bootstrap bagging procedure, variables selected as independently associated with higher log AUC Troponin were (i) lower TIMI flow, (ii) non-RCA culprit vessel, (iii) female gender, (iv) aspiration, (v) CFR post-PPCI, and (vi) CFR at Day 1, confirming that CFR post-PPCI and change in CFR between post-PPCI and Day 1 were independent predictors of log AUC Troponin. The IMR was not independently associated with log AUC Troponin ( Table 5) .
Relationship between endothelin, coronary flow reserve, and invasive measures stratified by ejection fraction
The time course for endothelin release is shown in Figure 5 .
In Group 1, endothelin levels remain elevated at 6 and 24 h compared with admission levels [2.28 (1.1-3.6) pg/mL and 1.6 (0.9 - Peak endothelin levels showed a significant relationship to 6-month EF and LGE (r ¼ 20. Coronary flow reserve and myocardial salvage
Discussion
The key findings from our study are that invasive measures of microcirculatory function in patients immediately following PCI for acute MI are a poor reflection of likely myocardial salvage. However, CFR measured the day following PPCI is significantly lower in patients with reduced EF compared with those patients with preserved EF. These differences in CFR also reflect significant observed differences in both MVO and haemorrhage imaged by MRI. In a multivariate analysis, 'both' the CFR at PPCI and the change in CFR over the first day related to myocardial salvage index. Systemic endothelin levels were significantly different between groups with low and high EF, with a different time course and more significant elevation for a longer duration in the group with lower EF. Furthermore, endothelin correlated with CFR at 24 h but not immediately after PPCI. These findings imply that measurement of microvascular function may change within individuals after infarction and that recovery of CFR over the first 24 h after PPCI is associated with better myocardial outcomes.
Published studies show that IMR measured at PPCI is associated with biochemical measures of infarct size, salvage, and relates to 3-month EF. 13, 14, 29 Our data confirm that using univariate analysis there is a relationship between IMR and infarct size. In this study, we wished to identify the optimal measures of microvascular function and so we stratified by tertiles and compared the lower tertile of EF patients with the upper two tertiles so that we could compare groups with clinically meaningful differences in EF.
Although relatively easy to perform, angiographic reflow was not different between patients with low and high EF. Using this approach, IMR measured at PPCI did not differentiate between the groups, but a preserved CFR at 24 h was significantly higher in the group with higher EF. To our knowledge, CFR has not been included in recent studies reporting PPCI IMR, and in the original study reporting the predictive value of IMR the authors recognized that small sample size may explain why other measures of microcirculatory function did not correlate with infarct size. Thus it appears that IMR measured at PPCI can differentiate large infarcts from small infarcts within a studied population, but the efficacy of reperfusion and the final outcome of individual patients are more complex than may have originally been considered. Our data highlight the importance of taking into account the changes of the microcirculation over the first 24 h in predictive models as we find associations between CFR at PPCI and that the change over 24 h relates to the prognostically important CMR salvage index 30 measured at 6 months with a 1-unit difference in CFR associated with 8% change in myocardial salvage relating to both PPCI and 24 h measures. A number of studies have investigated the concept that microvascular dysfunction after acute myocardial infarction is not fixed, and that the recovery of microvascular function is associated with reduced myocardial injury and improved functional outcome. Two studies have reported sequential invasive assessment of CFR in this context: Neumann described 19 patients in whom CFR of the infarct-related artery increased from 1.6 (post-stent) to 2.0 (after 1 h) and to 2.6 (after 14 days) after PPCI. 31 The very early change in CFR within the first hour correlated with biochemical measures of infarct size (peak CK), but not recovery of contractility. The majority of the change in CFR occurred within the first 2 days, assessed using PET, but the clinical impact of this change was not studied.
Lepper studied 25 patients and demonstrated a correlation between CFR and perfusion defects on MCE. In that study, patients with persistently abnormal CFR (,1.6 at PPCI and 24 h) had reduced wall motion score index compared with those that improved, but the relationship between changes in CFR and infarct size were not reported. 10 These studies differ from our larger study, in the context of contemporary PPCI practice, with associated short symptom-to-reperfusion times in a number of ways: (i) we have not used a specific cut-off value to define microcirculatory dysfunction and (ii) we have analysed outcomes using CMR salvage to take into account the influence of area-at-risk. The underlying mechanisms for the improvement or deterioration of CFR after successful PPCI are unknown. At a conceptual level, these can be considered as mechanical (perivascular oedema, haemorrhage, distal embolization of microthrombi) or vasoactive (abnormal vascular function, imbalance between dilatation and constriction). 32 Animal studies have shown that the area of microvascular dysfunction increases after reperfusion and can remain disturbed for some time after ischaemia-reperfusion injury. 33, 34 In our study, patients with low EF had more extensive imaging markers of mechanical disruption such as MVO and haemorrhage but in addition we also identified that there were important differences in circulating endothelin between these groups. Endothelin (ET-1) is a potent vasoconstrictor with effects mainly at the small resistance vessels. Endothelin levels increase 3-4 h after STEMI. High endothelin levels after PPCI are associated with CMR measures of MVO, lower salvage, and angiographic no-reflow. 35, 36 In animal models modulating endothelin can limit reperfusion injury. 37 A recent pilot clinical study demonstrated improved firstpass perfusion assessed by CMR in STEMI patients treated with shortterm endothelin type A receptor antagonist BQ123. 38 Our study investigated the time course release of endothelin and correlates these with invasive measures. The observation that more prolonged endothelin release maybe associated with adverse outcomes after STEMI and maybe a marker of microvascular dysfunction has been suggested previously. 36 Our study has found interesting correlations with CFR at 24 h. We cannot extrapolate any causal link, but endothelin blockade increases coronary blood flow in humans, suggesting that increased endothelin levels maybe contributing to the impairment of CFR in the group with low EF. The findings of this study have implications for improving the treatment of patients with acute STEMI. Our data highlight that a single measure of microvascular function performed after PPCI may not provide sufficient information to predict final outcomes. Importantly, we are not suggesting that repeat invasive assessment is indicated, but rather that these insights from clinical pathophysiology could support therapeutic approaches beyond the PPCI procedure itself. Thus, efforts to improve and/or prevent worsening of the coronary microcirculation in the first day after PPCI might reduce infarct size and optimize final outcome.
Limitations
There are a number of important limitations to our study. As with most invasive studies, small numbers limit our study and therefore these results should be considered hypothesis generating. However, the sequential approach allows patients to act as their own controls and the magnitude of physiological changes we describe are clinically meaningful. It has been suggested that the infarct-related microcirculation may have attenuated response to adenosine. CFR may be influenced by epicardial stenosis and baseline haemodynamics. However, we measured FFR and demonstrated no residual flow limiting lesions, nor found significant differences between baseline transit times suggesting no measurable difference in basal flow. However, CFR does not result from a simple comparison of two flow values as the ratio indicates, but rather from the area limited by the pressure -flow relations obtained in the presence and in the absence of arteriolar tone. Two flow measurements may lead to different values of CFR depending on the corresponding coronary pressure. To reflect microvascular abnormalities and changes, comparison at baseline and after 24 h must be made with identical coronary pressures and this maybe an important confounder in our analysis. Furthermore, we cannot account for confounding the influence of active cardiovascular medication taken prior to admission, although patients received standard therapy after PPCI.
